Q4 2021 13F Holders as of 31 Dec 2021
-
Type / Class
-
Equity / COM
-
Number of holders
-
149
-
Total 13F shares, excl. options
-
58,224,309
-
Shares change
-
+5,756,005
-
Total reported value, excl. options
-
$581,745,577
-
Value change
-
+$42,465,959
-
Put/Call ratio
-
88.3%
-
Number of buys
-
69
-
Number of sells
-
-84
-
Price
-
$9.99
Significant Holders of BLUEBIRD BIO INC - COM (BLUE) as of Q4 2021
204 filings reported holding BLUE - BLUEBIRD BIO INC - COM as of Q4 2021.
BLUEBIRD BIO INC - COM (BLUE) has 149 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 58,224,309 shares
.
Largest 10 shareholders include STATE STREET CORP (7,617,310 shares), VANGUARD GROUP INC (7,233,590 shares), WELLINGTON MANAGEMENT GROUP LLP (6,140,000 shares), BlackRock Inc. (5,912,002 shares), FIRST TRUST ADVISORS LP (5,204,825 shares), BAKER BROS. ADVISORS LP (2,499,715 shares), ARMISTICE CAPITAL, LLC (2,348,000 shares), JPMORGAN CHASE & CO (2,215,884 shares), CREDIT SUISSE AG/ (2,199,234 shares), and GOLDMAN SACHS GROUP INC (1,520,751 shares).
This table shows the top 149 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.